Zurich Cantonal Bank
EW icon

Zurich Cantonal Bank’s Edwards Lifesciences EW Stock Holding History

Zurich Cantonal Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-512,394
Closed -$43.7M – 2890
2025
Q4 		$43.7M Buy
+512,394
New +$42.1M 0.09% 178

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Zurich Cantonal Bank's EW Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Edwards Lifesciences (EW) stake by 6.5% in Q2 2026, selling an estimated $2.7M and leaving 465,371 shares worth $42.1M. The position accounts for 0.08% of the portfolio, ranked #194.

Zurich Cantonal Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Zurich Cantonal Bank held 465,371 shares of Edwards Lifesciences worth $42.1M as of Q2 2026.
  • Zurich Cantonal Bank sold 32,178 Edwards Lifesciences shares in Q2 2026, an estimated $2.7M.
  • Edwards Lifesciences made up 0.08% of Zurich Cantonal Bank's portfolio in Q2 2026, its #194 holding.
  • Zurich Cantonal Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.